Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,790
-1,080 (-7.79%)
At close: Dec 5, 2025

Oncocross Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
153,70975,179----
Enterprise Value
132,01662,376----
Last Close Price
12790.006340.00----
PS Ratio
173.7570.12----
PB Ratio
9.653.68----
P/TBV Ratio
9.683.68----
EV/Sales Ratio
149.2258.18----
Debt / Equity Ratio
0.320.030.010.050.20-1.14
Asset Turnover
0.040.050.010.010.01-
Quick Ratio
9.1811.3515.164.477.871.05
Current Ratio
9.4311.4215.254.597.931.06
Return on Equity (ROE)
-58.44%-35.10%-36.33%-114.08%--
Return on Assets (ROA)
-24.60%-21.69%-32.76%-53.18%-27.13%-
Return on Capital (ROIC)
-33.23%-23.15%-36.02%-61.28%-60.40%-
Return on Capital Employed (ROCE)
-31.40%-33.60%-41.30%-146.40%-55.20%-201.70%
Earnings Yield
-5.42%-8.62%----
FCF Yield
-6.22%-7.56%----
Buyback Yield / Dilution
-15.09%-17.49%-1.44%-63.74%-0.83%-
Source: S&P Capital IQ. Standard template. Financial Sources.